Author Correction: On-chip recapitulation of clinical bone marrow toxicities and patient-specific pathophysiology

Affiliations

• ¹ Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, MA, USA.
• ² Department of Pathology, Massachusetts General Hospital, Boston, MA, USA.
• ³ Clinical Pharmacology and Safety Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.
• ⁴ DMPK, Oncology R&D, AstraZeneca, Boston, MA, USA.
• ⁵ Clinical and Quantitative Pharmacology, Clinical Pharmacology and Safety Sciences, Pharmaceutical Sciences, R&D, AstraZeneca, Cambridge, UK.
• ⁶ Dana Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA.
• ⁷ Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, USA.
• ⁸ Department of Medicine, Harvard Medical School, Boston, MA, USA.
• ⁹ Department of Chemical Engineering, Loughborough University, Loughborough, UK.
• ¹⁰ Vascular Biology Program and Department of Surgery, Boston Children's Hospital and Harvard Medical School, Boston, MA, USA.
• ¹¹ Department of Bioengineering and Institute for Bioengineering and Biosciences (iBB), Instituto Superior Técnico, Universidade de Lisboa, Lisbon, Portugal.
• ¹² Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, USA.
• ¹³ Division of Bone Marrow Transplantation and Immune Deficiency, Cincinnati Children's Hospital, Cincinnati, OH, USA.
• ¹⁴ Department of Pathology, Boston Children's Hospital, Boston, MA, USA.
• ¹⁵ Broad Institute of Harvard and MIT, Cambridge, MA, USA.
• ¹⁶ Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, MA, USA. [email protected].
• ¹⁷ Vascular Biology Program and Department of Surgery, Boston Children's Hospital and Harvard Medical School, Boston, MA, USA. [email protected].
• ¹⁸ Harvard John A. Paulson School of Engineering and Applied Sciences, Cambridge, MA, USA. [email protected].